Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03057132 · ClinicalTrials.gov registry record · NA
Use of 3M Cavilon Advanced Skin Protectant in the Management of Damaged Skin Around an Ostomy, Drain or Fistula
A NA study, sponsored by Solventum US.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03057132 is a NA study that was terminated before completion, run by Solventum US. The registered enrollment target is 1 participants.
The verdict
NCT03057132, a NA study, was terminated before completion, sponsored by Solventum US.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The objective of this pilot study is to evaluate the feasibility, safety and efficacy of 3M™ Cavilon™ Advanced Skin Protectant when used in the management of damaged skin exposed to caustic body fluids from an ostomy, drain site or fistula.
Interventions
- DEVICE Cavilon Advanced Skin Protectant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03057132
The ClinicalTrials.gov registry entry for NCT03057132 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Solventum US, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cavilon Advanced Skin Protectant is the first listed.
NCT03057132 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03057132 about?
NCT03057132 is a clinical study titled "Use of 3M Cavilon Advanced Skin Protectant in the Management of Damaged Skin Around an Ostomy, Drain or Fistula". The objective of this pilot study is to evaluate the feasibility, safety and efficacy of 3M™ Cavilon™ Advanced Skin Protectant when used in the management of damaged skin exposed to caustic body fluids from an ostomy, drain site or fistula.
What is the current status of trial NCT03057132?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2016-11. Estimated completion is 2017-02.
What interventions are being tested in trial NCT03057132?
The interventions under investigation include: Cavilon Advanced Skin Protectant (DEVICE).
Who is sponsoring clinical trial NCT03057132?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.